NVN Liquidation Management
Management criteria checks 0/4
We currently do not have sufficient information about the CEO.
Key information
Scott Plesha
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | less than a year |
| CEO ownership | n/a |
| Management average tenure | 1.6yrs |
| Board average tenure | no data |
Recent management updates
Recent updates
CEO
Scott Plesha (58 yo)
less than a year
Tenure
Mr. Scott M. Plesha is Chief Executive Officer of Ligand Pharmaceuticals Incorporated from April 2024. Mr. Plesha had been the President of BioDelivery Sciences International, Inc. since December 2017 and...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chief Financial Officer | 5.3yrs | US$568.23k | 0.17% $ 0.05 | |
| CEO & Director | less than a year | no data | no data | |
| Senior VP & CTO | 5.3yrs | no data | no data | |
| Senior VP | less than a year | no data | no data | |
| Chief Medical Officer | 2.8yrs | no data | no data | |
| Senior Vice President of Manufacturing Operations | less than a year | no data | no data |
1.6yrs
Average Tenure
Experienced Management: 0A4P's management team is not considered experienced ( 1.6 years average tenure), which suggests a new team.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/05/02 02:55 |
| End of Day Share Price | 2024/04/08 00:00 |
| Earnings | 2023/03/31 |
| Annual Earnings | 2022/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
NVN Liquidation, Inc. is covered by 8 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Brian Kemp Dolliver | Brookline Capital Markets |
| Jennifer Kim | Cantor Fitzgerald & Co. |
| Oren Livnat | H.C. Wainwright & Co. |